The report GOLD-2025 updates the recommendations, incorporating new data on the prevalence, classification, diagnosis and treatment of COPD, with a focus on co-morbidities and the impact of climate change. It emphasize the need for a personalized, multidisciplinary approach to COPD management.

COPD: what's new in the Gold 2025 strategy?

These joint clinical guidelines from the ERS, EACTS and ESTS provide evidence-based recommendations for the management of spontaneous pneumothorax in adults. 
They examine various treatment options, from conservative management to surgery, depending on the severity and type of pneumothorax (primary or secondary). 
The analysis includes meta-analyses and a GRADE assessment of the quality of the evidence. 
Gaps in the evidence are highlighted, particularly concerning the management of persistent air leaks and the prevention of recurrence, with recommendations for future research. 
The guidelines incorporate patient perspectives and offer decision aids to guide clinical choices.

Podcast about the New ERS/EACTS/ESTS 2024 Guidelines on Spontaneous Pneumothorax Management

These extracts from the European Respiratory Society (ERS) guidelines present the results of a systematic review evaluating the efficacy and safety of using an inhaled corticosteroid (ICS)/formoterol as-needed in adult and adolescent patients with mild asthma. 
The ERS recommendations suggest the use of this combination in place of regular ICS and short-acting β2-agonist treatment on an as-needed basis in adults, and propose a similar approach or regular treatment in adolescents. 
The study analyzed several endpoints, including exacerbations, asthma control and exposure to systemic corticosteroids. Despite the low certainty of the evidence, the recommendations are based on a balance of benefits and risks, taking into account patients' values and preferences. 
Finally, the guidelines highlight the need for further research, particularly in paediatric populations and in countries where this treatment is not approved.

Podcast on European Respiratory Society guideline on Use of as-needed ICS/formoterol in mild asthma

This document is a clinical practice guideline (CPG) on the management of idiopathic pulmonary fibrosis (IPF) in Tunisia, developed jointly by STMRA and INEAS. 

It presents evidence-based recommendations adapted to the Tunisian context, covering diagnosis, initial workup, treatment (notably with nintedanib), follow-up, and management of comorbidities. The methodology used to develop the CPG, including bibliographic research and adaptation of international guidelines, is detailed. 

The guide includes recommendations graded according to the level of evidence, and includes tables and figures to illustrate the clinical, radiological and histopathological aspects of IPF.


Tunisian Idiopathic Pulmonary Fibrosis Clinical Practice Guideline

Intervenant : Dr Souissi Zouhair membre de la STMRA
En marge de la célébration de la 11 ème journée mondiale de lutte contre la BPCO du 14/11/2012
Le mardi 13/11/2012

Respiratory Channel